Europe — EMA
Zypadhera (Olanzapine)
Zypadhera (olanzapine) is an intramuscular antipsychotic injection used for managing agitation in schizophrenia and bipolar disorder. This extended-release form
Request sourcing
What is Olanzapine?
Zypadhera (olanzapine) is an intramuscular antipsychotic injection used for managing agitation in schizophrenia and bipolar disorder. This extended-release formulation provides sustained symptom control. Suitable for patients requiring rapid yet prolonged stabilization.
What is Olanzapine used for?
Zypadhera is used to calm severe agitation in adults with schizophrenia or bipolar disorder. It helps reduce symptoms like aggression, hostility, and restlessness when oral medication isn't feasible. The intramuscular route delivers prolonged effects compared to immediate-release options.
What are the side effects of Olanzapine?
Patients typically experience gradual symptom relief within hours of administration. The effects may last several days, supporting extended stabilization. Commonly reported outcomes include reduced agitation and improved ability to engage in care.
What precautions apply to Olanzapine?
Store at controlled room temperature away from light and moisture. Protect from freezing. Use only as prescribed by a healthcare professional. Keep out of reach of children and pets. Discard any unused portion after opening.
What does Olanzapine interact with?
Avoid combining with alcohol or sedatives due to increased drowsiness risk. Caution is advised with medications affecting the central nervous system. Consult a healthcare provider before using with blood pressure medications or anticholinergics.



